Loading...
Loading...
If you hold equity in a single startup — whether as an employee, founder, or advisor — you already understand concentration risk on a visceral level. Every product decision, every competitor funding announcement, every macroeconomic shift feels personal when your financial future is tied to a single outcome. The question most thoughtful equity holders eventually ask is: how many startups to diversify across to meaningfully reduce that risk? The answer, it turns out, is more nuanced than most people expect — and more accessible than it used to be.
In this article, we draw on decades of portfolio theory, venture capital research, and private wealth management practice to give you a concrete, research-backed answer. Whether you are an employee weighing whether to exercise options, a founder thinking about liquidity events, or an advisor structuring client portfolios, understanding the optimal startup portfolio size is the first step toward smarter equity management.
Most traditional diversification advice is designed for public market investors. The standard prescription — hold 15 to 20 stocks across different sectors — captures most of the available diversification benefit in a public equity context, where companies are liquid, transparently priced, and subject to continuous disclosure requirements. But startups are a fundamentally different asset class, and conventional wisdom built for public markets does not translate directly to private equity held by employees and founders.
The failure rate for venture-backed startups is notoriously high. According to data compiled by the Kauffman Foundation, one of the leading research institutions tracking entrepreneurial outcomes, roughly three-quarters of venture-backed companies fail to return investor capital. For employees and founders, the situation is even more concentrated: your equity is typically locked to a single company, illiquid for years, and often represents a significant share of your total net worth. This is the structural problem we have explored at length for startup stock and option holders — a challenge that demands a systematic diversification approach rather than passive hope.
The correlation structure of startups also differs dramatically from public equities. Two venture-backed companies in the same sector may respond very differently to identical macroeconomic conditions — one might capitalize on a regulatory shift while another stumbles over product-market fit challenges. This low and unpredictable correlation between individual startup outcomes is actually favorable for portfolio construction purposes. However, it also means that achieving return stability requires more positions than a comparable public equities strategy would demand.
Harry Markowitz's Modern Portfolio Theory, introduced in 1952, established the mathematical foundation for diversification as a risk management tool. The central insight is elegant: combining assets whose returns are not perfectly correlated reduces overall portfolio variance without proportionally sacrificing expected return. Research on public equity portfolios consistently shows that holding roughly 15 to 20 randomly selected stocks captures approximately 90 percent of the total diversification benefit available in equity markets.
The challenge is that Markowitz's framework assumes roughly normally distributed returns — not the binary, highly skewed return distributions that characterize early-stage startups. Venture-backed companies do not behave like utility stocks. The return distribution is deeply asymmetric: most investments return below their cost basis or produce modest multiples, while a small number generate returns of 10x, 50x, or more. This power-law dynamic fundamentally changes how we should approach the question of how many startups for diversification purposes — and why the public market rule of thumb consistently underestimates what startup portfolios actually require.
Academic research published in journals including the Journal of Finance has documented this asymmetry in detail. The variance of individual startup returns is orders of magnitude higher than individual public stock returns. More critically, analyses of venture fund portfolios show that in a typical fund, the top two or three investments often account for the majority of total fund returns. The practical implication is direct: when determining your startup diversification number, you need enough positions to give yourself a statistically reasonable probability of holding at least one of these transformative outcomes. Diversification in venture is not primarily about avoiding losses — it is about ensuring you are in the game when the rare outlier emerges.
Research from Cambridge Associates, which tracks performance data across thousands of venture portfolios globally, suggests that meaningful risk reduction in startup investing begins around 15 to 20 companies. Below this threshold, the probability that a single catastrophic loss overwhelms total portfolio performance remains high. Above 20 companies, the marginal risk reduction from each additional position diminishes — but the expected probability of holding a breakout outcome continues to improve meaningfully through the 40 to 50 company range.
More rigorous quantitative analysis, drawing on simulation studies of venture portfolio outcomes, suggests that to maintain a reasonable probability of capturing a genuinely transformative return — the kind that drives total portfolio performance — an investor likely needs between 25 and 50 positions. Below 20 holdings, simulation analysis consistently shows that portfolio outcomes remain highly sensitive to the fate of individual companies. Above 50, the incremental diversification benefit flattens considerably. The question of how many startups for diversification that yields the best risk-adjusted return therefore points consistently toward this 25 to 50 range for most individual investors without institutional-grade deal flow advantages.
In my experience watching concentrated equity positions play out across multiple market cycles, I have seen too many talented people — engineers, product leaders, early-stage employees — walk away with far less than they deserved simply because all of their financial upside was tied to a single outcome. The individuals who have built meaningful, lasting wealth from startup equity almost invariably had systematic exposure to multiple companies. Not because they were luckier, but because they understood that diversification is the one edge that requires no special skill or proprietary information — only discipline, structure, and access.
To make the startup diversification number concrete, here is how portfolio size maps to practical risk profile:
The research is clear that broader diversification generally improves risk-adjusted outcomes — but achieving an optimal startup portfolio size of 20 to 50 companies is not merely a mathematical exercise for most individuals. It runs directly into practical constraints that must be acknowledged honestly.
Capital requirements represent the most immediate barrier. Early-stage startup investments typically carry minimum check sizes ranging from $25,000 to $100,000 or more per company. To build a 30-company portfolio at those minimums, an investor would need between $750,000 and $3 million committed to startup equity alone — before factoring in follow-on reserves. For the vast majority of employees and founders, even those with substantial paper wealth on a cap table, this level of liquid capital dedicated to startup investing is simply not available.
Access to quality deal flow is the second significant constraint. High-quality startups — those with genuine upside potential, defensible market positions, and strong institutional co-investors — are not universally accessible. A portfolio of 30 undifferentiated companies does not offer the same risk-adjusted return profile as 20 carefully selected high-potential businesses. The diversification mathematics assume that underlying positions offer real return potential, not simply a broad spread of mediocrity. Before making decisions about your own equity strategy, tools like the Equity Simulator can help you model the range of outcomes under different portfolio assumptions and risk scenarios.
Stage and sector concentration deserve equal attention. A portfolio composed entirely of Series A enterprise software companies is far less diversified than one spanning seed-stage consumer startups, growth-stage climate technology companies, and late-stage healthcare businesses. Genuine portfolio diversification requires breadth across stages, sectors, and geographies — not simply a higher count of distinct company names. The startup diversification number is a necessary condition for adequate diversification, but it is not sufficient on its own.
It is tempting to treat portfolio construction as a purely numerical exercise — acquire the right startup diversification number of positions and consider the job done. But practitioners know better. Research compiled by the National Venture Capital Association consistently shows that top-quartile venture funds do not simply hold more positions than their peers. They outperform because they have systematic sourcing advantages, rigorous diligence processes, and the ability to actively support portfolio companies through capital access and strategic network introductions. The number of positions matters — but so does the quality of each one.
For individual equity holders, several guiding principles follow from this. First, quality within your diversification strategy matters at least as much as quantity. A portfolio of 15 to 20 carefully selected, high-conviction positions — backed by genuine research and access to quality deal flow — will typically outperform a portfolio of 50 companies assembled without discipline. The research figures discussed earlier assume roughly representative company selection; to the extent you can systematically tilt toward higher-quality companies, the optimal startup portfolio size required for adequate diversification decreases accordingly.
Second, consider the information advantage embedded in your current concentrated position. As an employee who understands your company's product, team, and competitive dynamics intimately, you may have insight that a passive investor lacks. That informational edge does not eliminate concentration risk — companies can fail for reasons no insider anticipates — but it does affect how to think about portfolio weightings. Third, recognize that diversification is dynamic. The optimal startup portfolio size is not a static target. It should evolve as individual positions mature, approach liquidity events, or fail. Active and ongoing portfolio management is not optional for serious equity holders.
For most equity holders, the practical barriers to independently building a 20 to 50 company portfolio are genuinely prohibitive — not as a theoretical concern, but as a financial reality. Equity pooling is a structure designed specifically to close this gap. As covered in our Introduction to Equity Pooling, this approach allows startup equity holders to exchange their concentrated single-company positions for diversified exposure across a portfolio of multiple companies simultaneously — converting a concentrated risk into a diversified one without requiring individual investors to source and fund dozens of separate positions.
This structure directly addresses the core tension between the theoretically optimal startup portfolio size and the practical barriers that prevent most individuals from achieving it independently. You do not need multi-million dollar minimum commitments. You do not need institutional-grade deal flow or a partner-level relationship at a top-tier venture firm. What you need is a counterparty structure that can exchange your concentrated single-company exposure for a diversified portfolio position — and that is precisely what equity pooling platforms are designed to provide.
The quality constraint is addressed as well. When you participate in a curated equity pool, the portfolio construction decisions — company selection, sector allocation, stage diversification — are made by professionals with systematic sourcing capabilities and institutional diligence processes. This is not merely about achieving the right startup diversification number on paper; it is about reaching that number with positions that carry genuine upside potential. As we have argued in our piece on equity pooling as a social good, diversified access to startup equity should not be the exclusive province of institutional limited partners. The employees and founders who build these companies deserve access to diversification tools that have historically been available only to their investors.
The question of how many startups to diversify across does not yield a single universal answer, but decades of portfolio theory and venture capital research converge on a practical range: somewhere between 20 and 50 companies provides meaningful risk reduction alongside a reasonable probability of participating in transformative outcomes. Below 20 positions, concentration risk remains substantial. Above 50, incremental diversification benefits diminish considerably, though institutional investors with top-tier deal flow often hold well beyond that threshold. What matters alongside the number is the quality and breadth of the underlying positions — and your ability to access those positions at reasonable cost. If you are ready to explore what diversification could look like for your specific equity holdings, you can get an offer through Aption to see how equity pooling might apply to your situation.
The author name used in this article may be a pen name or pseudonym and is used for illustrative and editorial purposes only. This article is for informational purposes only and does not constitute investment, tax, or legal advice. All research references and figures cited are provided for general educational purposes and should not be construed as guarantees of future performance or specific investment recommendations. Past performance of any portfolio strategy, including diversified startup investing, is not indicative of future results. Consult qualified professionals before making financial decisions regarding your equity holdings or investment strategy.
Michael is a financial analyst and equity markets researcher who covers startup valuations, secondary markets, and alternative investment vehicles. He previously led equity research at a top-tier investment bank.